Protection of vascular endothelium by aspirin in a murine model of chronic Chagas’ disease-Reference-Cited by-同舟云学术

Protection of vascular endothelium by aspirin in a murine model of chronic Chagas’ disease

Published:2013-05-17 Issue:7 Volume:112 Page:2731-2739
ISSN:0932-0113
Container-title:Parasitology Research
language:en
Short-container-title:Parasitol Res

Author:

Molina-Berríos Alfredo,Campos-Estrada Carolina,Lapier Michel,Duaso Juan,Kemmerling Ulrike,Galanti Norbel,Ferreira Jorge,Morello Antonio,López-Muñoz Rodrigo,Maya Juan Diego

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Insect Science,General Veterinary,General Medicine,Parasitology

Link

http://link.springer.com/content/pdf/10.1007/s00436-013-3444-x.pdf

Reference53 articles.

1. Abdalla GK, Faria GE, Silva KT, Castro EC, Reis MA, Michelin MA (2008) Trypanosoma cruzi: the role of PGE2 in immune response during the acute phase of experimental infection. Exp Parasitol 118(4):514–521. doi: 10.1016/j.exppara.2007.11.003

2. Al-Mutairi M, Al-Harthi S, Cadalbert L, Plevin R (2010) Over-expression of mitogen-activated protein kinase phosphatase-2 enhances adhesion molecule expression and protects against apoptosis in human endothelial cells. Br J Pharmacol 161(4):782–798. doi: 10.1111/j.1476-5381.2010.00952.x

3. Andrade D, Serra R, Svensjo E, Lima AP, Ramos ES Jr, Fortes FS, Morandini AC, Morandi V, Soeiro Mde N, Tanowitz HB, Scharfstein J (2012) Trypanosoma cruzi invades host cells through the activation of endothelin and bradykinin receptors: a converging pathway leading to chagasic vasculopathy. Br J Pharmacol 165(5):1333–1347. doi: 10.1111/j.1476-5381.2011.01609.x

4. Ashton AW, Mukherjee S, Nagajyothi FN, Huang H, Braunstein VL, Desruisseaux MS, Factor SM, Lopez L, Berman JW, Wittner M, Scherer PE, Capra V, Coffman TM, Serhan CN, Gotlinger K, Wu KK, Weiss LM, Tanowitz HB (2007) Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J Exp Med 204(4):929–940

5. Barbosa AP, Cardinalli Neto A, Otaviano AP, Rocha BF, Bestetti RB (2011) Comparison of outcome between Chagas’ cardiomyopathy and idiopathic dilated cardiomyopathy. Arq. Comparison of outcome between Chagas’ cardiomyopathy and idiopathic dilated cardiomyopathy Arq Bras Cardiol 97(6):517–525

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin and aspirin use in parasitic infections as a potential therapeutic strategy: A narrative review;Revista Argentina de Microbiología;2023-07

2. Coronary microvascular dysfunction due to Chagas disease: where are we now?;Expert Review of Cardiovascular Therapy;2023-05-24

3. Effect of statins on inflammation and cardiac function in patients with chronic Chagas disease: A protocol for pathophysiological studies in a multicenter, placebo-controlled, proof-of-concept phase II trial;PLOS ONE;2023-01-13

4. Aspirin and Infection: A Narrative Review;Biomedicines;2022-01-25

5. The Oxidative Stress and Chronic Inflammatory Process in Chagas Disease: Role of Exosomes and Contributing Genetic Factors;Oxidative Medicine and Cellular Longevity;2021-12-23